Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 28

1.

Identification of the active site of human mitochondrial malonyl-coenzyme a decarboxylase: A combined computational study.

Ling B, Liu Y, Li X, Wang Z, Bi S.

Proteins. 2016 Jun;84(6):792-802. doi: 10.1002/prot.25029. Epub 2016 Mar 25.

PMID:
26948533
2.

A new case of malonyl-CoA decarboxylase deficiency with mild clinical features.

Liu H, Tan D, Han L, Ye J, Qiu W, Gu X, Zhang H.

Am J Med Genet A. 2016 May;170A(5):1347-51. doi: 10.1002/ajmg.a.37590. Epub 2016 Feb 9.

PMID:
26858006
3.

Structural asymmetry and disulfide bridges among subunits modulate the activity of human malonyl-CoA decarboxylase.

Aparicio D, Pérez-Luque R, Carpena X, Díaz M, Ferrer JC, Loewen PC, Fita I.

J Biol Chem. 2013 Apr 26;288(17):11907-19. doi: 10.1074/jbc.M112.443846. Epub 2013 Mar 11.

4.

Malonyl coenzyme A decarboxylase deficiency: early dietary restriction and time course of cardiomyopathy.

Prada CE, Jefferies JL, Grenier MA, Huth CM, Page KI, Spicer RL, Towbin JA, Leslie ND.

Pediatrics. 2012 Aug;130(2):e456-60. doi: 10.1542/peds.2011-2927. Epub 2012 Jul 9.

PMID:
22778304
5.

Clinical, enzymatic and molecular characterization of nine new patients with malonyl-coenzyme A decarboxylase deficiency.

Salomons GS, Jakobs C, Pope LL, Errami A, Potter M, Nowaczyk M, Olpin S, Manning N, Raiman JA, Slade T, Champion MP, Peck D, Gavrilov D, Hillman R, Hoganson GE, Donaldson K, Shield JP, Ketteridge D, Wasserstein M, Gibson KM.

J Inherit Metab Dis. 2007 Feb;30(1):23-8. Epub 2006 Dec 20.

PMID:
17186413
6.

Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation.

Cuthbert KD, Dyck JR.

Curr Hypertens Rep. 2005 Dec;7(6):407-11. Review.

PMID:
16386195
7.

MLYCD mutation analysis: evidence for protein mistargeting as a cause of MLYCD deficiency.

Wightman PJ, Santer R, Ribes A, Dougherty F, McGill N, Thorburn DR, FitzPatrick DR.

Hum Mutat. 2003 Oct;22(4):288-300.

PMID:
12955715
8.

Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations.

Froese DS, Forouhar F, Tran TH, Vollmar M, Kim YS, Lew S, Neely H, Seetharaman J, Shen Y, Xiao R, Acton TB, Everett JK, Cannone G, Puranik S, Savitsky P, Krojer T, Pilka ES, Kiyani W, Lee WH, Marsden BD, von Delft F, Allerston CK, Spagnolo L, Gileadi O, Montelione GT, Oppermann U, Yue WW, Tong L.

Structure. 2013 Jul 2;21(7):1182-92. doi: 10.1016/j.str.2013.05.001. Epub 2013 Jun 20.

9.

Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension.

Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, Lopaschuk GD, Dyck JR, Michelakis ED.

Sci Transl Med. 2010 Aug 11;2(44):44ra58. doi: 10.1126/scitranslmed.3001327.

10.

Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.

Bouzakri K, Austin R, Rune A, Lassman ME, Garcia-Roves PM, Berger JP, Krook A, Chibalin AV, Zhang BB, Zierath JR.

Diabetes. 2008 Jun;57(6):1508-16. doi: 10.2337/db07-0583. Epub 2008 Feb 26.

11.

Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle.

Kuhl JE, Ruderman NB, Musi N, Goodyear LJ, Patti ME, Crunkhorn S, Dronamraju D, Thorell A, Nygren J, Ljungkvist O, Degerblad M, Stahle A, Brismar TB, Andersen KL, Saha AK, Efendic S, Bavenholm PN.

Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1296-303. Epub 2006 Jan 24.

13.

Expression, purification, and characterization of human malonyl-CoA decarboxylase.

Zhou D, Yuen P, Chu D, Thon V, McConnell S, Brown S, Tsang A, Pena M, Russell A, Cheng JF, Nadzan AM, Barbosa MS, Dyck JR, Lopaschuk GD, Yang G.

Protein Expr Purif. 2004 Apr;34(2):261-9.

PMID:
15003260
14.

MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency.

Sacksteder KA, Morrell JC, Wanders RJ, Matalon R, Gould SJ.

J Biol Chem. 1999 Aug 27;274(35):24461-8.

15.

The molecular basis of malonyl-CoA decarboxylase deficiency.

FitzPatrick DR, Hill A, Tolmie JL, Thorburn DR, Christodoulou J.

Am J Hum Genet. 1999 Aug;65(2):318-26.

16.

Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase.

Gao J, Waber L, Bennett MJ, Gibson KM, Cohen JC.

J Lipid Res. 1999 Jan;40(1):178-82.

17.

Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart.

Yatscoff MA, Jaswal JS, Grant MR, Greenwood R, Lukat T, Beker DL, Rebeyka IM, Lopaschuk GD.

Pediatr Res. 2008 Dec;64(6):643-7. doi: 10.1203/PDR.0b013e318184d281.

PMID:
18614968
18.

A proteome-wide perspective on peroxisome targeting signal 1(PTS1)-Pex5p affinities.

Ghosh D, Berg JM.

J Am Chem Soc. 2010 Mar 24;132(11):3973-9. doi: 10.1021/ja9109049.

PMID:
20178365
19.

Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.

Lu Y, Dollé ME, Imholz S, van 't Slot R, Verschuren WM, Wijmenga C, Feskens EJ, Boer JM.

J Lipid Res. 2008 Dec;49(12):2582-9. doi: 10.1194/jlr.M800232-JLR200. Epub 2008 Jul 25.

20.

Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.

Floyd BJ, Wilkerson EM, Veling MT, Minogue CE, Xia C, Beebe ET, Wrobel RL, Cho H, Kremer LS, Alston CL, Gromek KA, Dolan BK, Ulbrich A, Stefely JA, Bohl SL, Werner KM, Jochem A, Westphall MS, Rensvold JW, Taylor RW, Prokisch H, Kim JP, Coon JJ, Pagliarini DJ.

Mol Cell. 2016 Aug 18;63(4):621-632. doi: 10.1016/j.molcel.2016.06.033. Epub 2016 Aug 4.

Supplemental Content

Support Center